Phase I imaging study of the HER3 antibody RG7116 using 89 Zr-RG7116-PET in patients with metastatic or locally advanced HER3-positive solid tumors

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 32; no. 15_suppl; p. 11095
Main Authors Bensch, Frederike, Lamberts, Laetitia E., Lub-de Hooge, Marjolijn N., Terwisscha van Scheltinga, Anton G.T., de Jong, Johan R., Gietema, Jourik A., Schroder, Carolien P., Smeenk, Michiel M., Jacob, Wolfgang, Abiraj, Keelara, Wolf, Michaela, Adessi, Celine, Meneses-Lorente, Georgina, Zajac, Magdalena, Weisser, Martin, Brouwers, Adrienne H., De Vries, Elisabeth
Format Journal Article
LanguageEnglish
Published 20.05.2014
Online AccessGet full text

Cover

Abstract Abstract only
AbstractList Abstract only
Author De Vries, Elisabeth
Smeenk, Michiel M.
Adessi, Celine
Bensch, Frederike
Schroder, Carolien P.
Lamberts, Laetitia E.
Lub-de Hooge, Marjolijn N.
Jacob, Wolfgang
Wolf, Michaela
Meneses-Lorente, Georgina
Brouwers, Adrienne H.
de Jong, Johan R.
Zajac, Magdalena
Weisser, Martin
Abiraj, Keelara
Terwisscha van Scheltinga, Anton G.T.
Gietema, Jourik A.
Author_xml – sequence: 1
  givenname: Frederike
  surname: Bensch
  fullname: Bensch, Frederike
  organization: Department of Medical Oncology, University Medical Center Groningen, Groningen, Netherlands
– sequence: 2
  givenname: Laetitia E.
  surname: Lamberts
  fullname: Lamberts, Laetitia E.
  organization: Department of Medical Oncology, University Medical Center Groningen, Groningen, Netherlands
– sequence: 3
  givenname: Marjolijn N.
  surname: Lub-de Hooge
  fullname: Lub-de Hooge, Marjolijn N.
  organization: Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, Netherlands
– sequence: 4
  givenname: Anton G.T.
  surname: Terwisscha van Scheltinga
  fullname: Terwisscha van Scheltinga, Anton G.T.
  organization: Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, Netherlands
– sequence: 5
  givenname: Johan R.
  surname: de Jong
  fullname: de Jong, Johan R.
  organization: Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, Netherlands
– sequence: 6
  givenname: Jourik A.
  surname: Gietema
  fullname: Gietema, Jourik A.
  organization: Department of Medical Oncology, University Medical Center Groningen, Groningen, Netherlands
– sequence: 7
  givenname: Carolien P.
  surname: Schroder
  fullname: Schroder, Carolien P.
  organization: Department of Medical Oncology, University Medical Center Groningen, Groningen, Netherlands
– sequence: 8
  givenname: Michiel M.
  surname: Smeenk
  fullname: Smeenk, Michiel M.
  organization: Department of Medical Oncology, University Medical Center Groningen, Groningen, Netherlands
– sequence: 9
  givenname: Wolfgang
  surname: Jacob
  fullname: Jacob, Wolfgang
  organization: Roche Pharma Research and Early Development (pRED), Penzberg, Germany
– sequence: 10
  givenname: Keelara
  surname: Abiraj
  fullname: Abiraj, Keelara
  organization: Roche Pharma Research and Early Development (pRED), Basel, Switzerland
– sequence: 11
  givenname: Michaela
  surname: Wolf
  fullname: Wolf, Michaela
  organization: Roche Pharma Research and Early Development (pRED), Basel, Switzerland
– sequence: 12
  givenname: Celine
  surname: Adessi
  fullname: Adessi, Celine
  organization: Roche Pharma Research and Early Development (pRED), Basel, Switzerland
– sequence: 13
  givenname: Georgina
  surname: Meneses-Lorente
  fullname: Meneses-Lorente, Georgina
  organization: Roche Pharma Research & Early Development Oncology, Welwyn, United Kingdom
– sequence: 14
  givenname: Magdalena
  surname: Zajac
  fullname: Zajac, Magdalena
  organization: Roche Products, Ltd, Welwyn, England
– sequence: 15
  givenname: Martin
  surname: Weisser
  fullname: Weisser, Martin
  organization: Roche Pharma Research and Early Development (pRED), Penzberg, Germany
– sequence: 16
  givenname: Adrienne H.
  surname: Brouwers
  fullname: Brouwers, Adrienne H.
  organization: Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, Netherlands
– sequence: 17
  givenname: Elisabeth
  surname: De Vries
  fullname: De Vries, Elisabeth
  organization: University Medical Center Groningen, Groningen, Netherlands
BookMark eNo10N9KwzAUBvAgCm7Tdzh435qTNE3rncjcBMExJog3IUtTF-ma0qTKnsMXtvPP1YGP830Xvyk5bX1rCblCmiKj9Prd-JRRzFLOUhQqDF3XpIi0FCdkgoLJREohTsmESs4SLPjLOZmG8E7HTsHFhHytdjpYeAC312-ufYMQh-oAvoa4s7CcrznoNrqtH8P1QiLmMITjX1HCa5_8RslqvgHXQqejs20M8OniDvY26hDHyIDvofFGN80BdPWhW2Orn-2k88FF92Eh-MZVEIe978MFOat1E-zl352R5_v55m6ZPD4tHu5uHxODtBBJJrOMsVxSYxkvKK-NQZSmyJAxbXOklOdSsDKrygqxtFuJQmZsW1me17VGPiM3v7um9yH0tlZdPzL0B4VUHXnVyKuOvIoz9c-rfnj5NzVNcXs
CitedBy_id crossref_primary_10_1002_med_21498
crossref_primary_10_1016_j_ccr_2022_215005
crossref_primary_10_1002_adfm_201910402
crossref_primary_10_1200_JCO_2014_57_8278
crossref_primary_10_2967_jnumed_116_181586
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1200/jco.2014.32.15_suppl.11095
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1527-7755
EndPage 11095
ExternalDocumentID 10_1200_jco_2014_32_15_suppl_11095
GroupedDBID ---
.55
0R~
18M
2WC
34G
39C
4.4
53G
5GY
5RE
8F7
AARDX
AAWTL
AAYEP
AAYOK
AAYXX
ABJNI
ABOCM
ACGFO
ACGFS
ACGUR
ADBBV
AEGXH
AENEX
AIAGR
ALMA_UNASSIGNED_HOLDINGS
AWKKM
BAWUL
C45
CITATION
CS3
DIK
EBS
EJD
F5P
F9R
FBNNL
FD8
GX1
H13
HZ~
IH2
KQ8
L7B
LSO
MJL
N9A
O9-
OK1
OVD
OWW
P2P
QTD
R1G
RHI
RLZ
RUC
SJN
SV3
TEORI
TR2
TWZ
UDS
VVN
WH7
X7M
YCJ
YFH
YQY
ID FETCH-LOGICAL-c1085-474422670ce23803fcc117c84122ae61003675294d9d119eb715742bde36ffa13
ISSN 0732-183X
IngestDate Fri Aug 23 04:09:26 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 15_suppl
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1085-474422670ce23803fcc117c84122ae61003675294d9d119eb715742bde36ffa13
PageCount 1
ParticipantIDs crossref_primary_10_1200_jco_2014_32_15_suppl_11095
PublicationCentury 2000
PublicationDate 2014-05-20
PublicationDateYYYYMMDD 2014-05-20
PublicationDate_xml – month: 05
  year: 2014
  text: 2014-05-20
  day: 20
PublicationDecade 2010
PublicationTitle Journal of clinical oncology
PublicationYear 2014
SSID ssj0014835
Score 2.1604614
Snippet Abstract only
SourceID crossref
SourceType Aggregation Database
StartPage 11095
Title Phase I imaging study of the HER3 antibody RG7116 using 89 Zr-RG7116-PET in patients with metastatic or locally advanced HER3-positive solid tumors
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF61RUJcELQg3poD6sW1idcbP46A0qaIVlFxpYiL5V2vVQdiI8cBhb_BH2bW61coCOjFSjbJyPZ8mZ1dz_cNIS9VjyN3JFOTuZyZzJcYBx3BTCGTwE5ZkgY1Sezs3J1esnfz8Xxn92BQtbSuuCW-_5ZXchOv4hj6VbFk_8OznVEcwNfoXzyih_H4Tz6eXeEcZJwa2VL3Glq1CtEqm5xOLhwD71vGCxy8OPFs2zXW9daAHxgfS1MPmbNJaPQCqw3bbSmrWHGNMqEK1usJ7_OmLxhQtk1d7_VVGniRWWJU62XRPBq6nux2BMwiF1sb-W9wGa27UR2XStci-9Qh7X2smpVUK03fVmy4LDYmVvfxmpsJXmZRNN3h43KBJ7LIjfPuO6EsvyGyxFVc9yf-oMpeVZ133OgmKEkRK7SGWx82U0_t6WgQIT2HmhiT5noyayI49XDJoLV_2xDfb6EqKI-jleqYOgjbSnZ1PMgBuvfXJhha985eCMUbtZnlUKs1Zw2MDFW9f5ltuxpItfpCaxHaipStyKFRayuqbe2SWxTDp4rbJ_OucAnXr7ptbHvxjZQu2nr15_MapF2D_Cm8R-42WIDXGsX3yY7M98nts6a0Y58czrSI-uYIwp4TuDqCQ5j18uqbA_KjRj2cQoN6qFEPRQqIelDIhBb1oCEONerBD2AL9ZDl0KIeFOqhRz0UJTSohxb1sIV6qFEPGvUPyOXxJHw7NZvWIqao6TbMY4pC7o2ExJx15KRC2LYnfGZTGktcUmBi541pwJIgse1Acs8ee4zyRDpumsa285Ds5UUuHxFIglT4Hpdc0JhxJ8Bw56epO-KcuvEo4I-J09756ItWkIn-7vsnN_rVU3Kn_588I3tVuZbPMWmu-IsaQz8BHdS_TA
link.rule.ids 315,783,787,27936,27937
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phase+I+imaging+study+of+the+HER3+antibody+RG7116+using+89+Zr-RG7116-PET+in+patients+with+metastatic+or+locally+advanced+HER3-positive+solid+tumors&rft.jtitle=Journal+of+clinical+oncology&rft.au=Bensch%2C+Frederike&rft.au=Lamberts%2C+Laetitia+E.&rft.au=Lub-de+Hooge%2C+Marjolijn+N.&rft.au=Terwisscha+van+Scheltinga%2C+Anton+G.T.&rft.date=2014-05-20&rft.issn=0732-183X&rft.eissn=1527-7755&rft.volume=32&rft.issue=15_suppl&rft.spage=11095&rft.epage=11095&rft_id=info:doi/10.1200%2Fjco.2014.32.15_suppl.11095&rft.externalDBID=n%2Fa&rft.externalDocID=10_1200_jco_2014_32_15_suppl_11095
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0732-183X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0732-183X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0732-183X&client=summon